LncRNAs in the Type I Interferon Antiviral Response

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• The immune system must balance antiviral defense against overactivation to prevent autoimmunity and cancer.
• Type I interferon (IFN) signaling pathways regulate the magnitude and duration of antiviral responses.
• Regulation occurs at DNA, RNA, and protein levels, involving antiviral and proinflammatory factors.

Purpose of the Study:

• To review the role of long non-coding RNAs (lncRNAs) in regulating antiviral immune responses.
• To highlight how lncRNAs modulate viral replication and immune activation.
• To explore the potential of lncRNAs as biomarkers and therapeutic agents.

Main Methods:

• Review of recent research on lncRNAs and their involvement in antiviral immunity.
• Analysis of lncRNA regulation of type I interferon signaling pathways.
• Examination of lncRNA specificity in different tissues and cell types.

Main Results:

• Long non-coding RNAs (lncRNAs) are key regulators of antiviral immunity.
• Viruses and immune responses alter lncRNA expression, impacting viral replication.
• lncRNAs can either promote or repress antiviral activity by modulating IFN pathways.

Conclusions:

• lncRNAs play a critical role in controlling the immune system's response to viral infections.
• IFN-related lncRNAs exhibit tissue- and cell-type specificity.
• These lncRNAs represent promising candidates for targeted therapies to manage viral infections and immune dysregulation.